Prognostic role of PIK3CA mutations of cell‐free DNA in early‐stage triple negative breast cancer

類似資料

• Clinical significance of monitoring ESR1 mutations in circulating cell-free DNA in estrogen receptor positive breast cancer patients
  著者:: Takeshita, Takashi, 等
  出版事項: (2016)
• Analysis of ESR1 and PIK3CA mutations in plasma cell-free DNA from ER-positive breast cancer patients
  著者:: Takeshita, Takashi, 等
  出版事項: (2017)
• An integrative analysis of PIK3CA mutation, PTEN, and INPP4B expression in terms of trastuzumab efficacy in HER2-positive breast cancer.
  著者:: Aiko Sueta, 等
  出版事項: (2014-01-01)
• An Integrative Analysis of PIK3CA Mutation, PTEN, and INPP4B Expression in Terms of Trastuzumab Efficacy in HER2-Positive Breast Cancer
  著者:: Sueta, Aiko, 等
  出版事項: (2014)
• Clinical significance of plasma cell-free DNA mutations in PIK3CA, AKT1, and ESR1 gene according to treatment lines in ER-positive breast cancer
  著者:: Takeshita, Takashi, 等
  出版事項: (2018)